New arylthioindoles: Potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies

被引:371
作者
De Martino, G
Edler, MC
La Regina, G
Coluccia, A
Barbera, MC
Barrow, D
Nicholson, RI
Chiosis, G
Brancale, A
Hamel, E
Artico, M
Silvestri, R
机构
[1] Univ Roma La Sapienza, Dipartimento Studi Farmaceut, Fdn Cenci Bolognetti, Ist Pasteur, I-00185 Rome, Italy
[2] Cardiff Univ, Welsh Sch Pharm, Cardiff CF10 3XF, Wales
[3] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA
[4] NCI, Toxicol & Pharmacol Branch, Dev Therapeut Program, Div Canc Treatment & Diag,NIH, Frederick, MD 21702 USA
[5] Cardiff Univ, Welsh Sch Pharm, Tenovus Ctr Canc Res, Cardiff CF10 3XF, Wales
关键词
D O I
10.1021/jm050809s
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Arylthioindoles (ATIs) that possess a 3-methoxyphenylthio or a 3,5-dimethoxyphenylthio moiety at position 2 of the indole ring were effective tubulin assembly inhibitors, but weak inhibitors of MCF-7 cell growth. ATIs bearing a 3-(3,4,5-trimethoxyphenyl)thio moiety were potent tubulin polymerization inhibitors, with IC(50)s in the 2.0 (35) to 4.5 (37) mu M range. They also inhibited MCF-7 cell growth at nanomolar concentrations. The 3,4,5-trimethoxy substituted ATIs showed potencies comparable to those of the reference compounds colchicine and combretastatin A-4 in both tubulin assembly and cell growth inhibition assays. Dynamics simulation studies correlate well with the observed experimental data. Furthermore, from careful analysis of the biological and in silico data, we can now hypothesize a basic pharmacophore for this class of compounds.
引用
收藏
页码:947 / 954
页数:8
相关论文
共 34 条
[31]   Novel indolyl aryl sulfones active against HIV-1 carrying NNRTI resistance mutations: Synthesis and SAR studies [J].
Silvestri, R ;
De Martino, G ;
La Regina, G ;
Artico, M ;
Massa, S ;
Vargiu, L ;
Mura, M ;
Loi, AG ;
Marceddu, T ;
La Colla, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (12) :2482-2493
[32]  
Soltau J, 2004, IDRUGS, V7, P380
[33]  
*TRIP INC, TRIP SYBYL
[34]   Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells [J].
Verdier-Pinard, P ;
Lai, JY ;
Yoo, HD ;
Yu, JR ;
Marquez, B ;
Nagle, DG ;
Nambu, M ;
White, JD ;
Falck, JR ;
Gerwick, WH ;
Day, BW ;
Hamel, E .
MOLECULAR PHARMACOLOGY, 1998, 53 (01) :62-76